Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trialsA Blauvelt, K Reich, M Lebwohl, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 2, 2014
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)K A Papp, K Barber, R Bissonnette, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2015
Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINEK A Papp, K Barber, R Bissonnette, et al.Pediatric Dermatology|March 18, 2000
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotypeZ Urbán, S Peyrol, H Plauchu, et al.Journal of Cutaneous Medicine and Surgery|December 26, 2001
Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelinesW S Madden, I D Landells, Y Poulin, et al.The British Journal of Dermatology|July 17, 2016
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trialR Bissonnette, K A Papp, Y Poulin, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trialB E Elewski, C S Baker, J J Crowley, et al.Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 29, 2014
Physician perceptions and experience of current treatment in actinic keratosisE Stockfleth, K Peris, C Guillen, et al.The British Journal of Dermatology|July 12, 2020
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2)K B Gordon, R B Warren, A B Gottlieb, et al.Pageof 16